SCHEMBL6003293

SCHEMBL6003293

c1ccc(OCc2ccc3ncsc3c2)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 1/20 0.47
ALDH1A1 P00352 1/20 0.47
HSD17B10 Q99714 1/20 0.47
APP P05067 1/20 0.46
TDP1 Q9NUW8 3/20 0.45
NPC1 O15118 2/20 0.45
RAB9A P51151 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
KDM4E B2RXH2 2/20 0.45
HKDC1 Q2TB90 1/20 0.45
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAOB P27338 1/20 0.42
IKBKB O14920 1/20 0.42
F10 P00742 1/20 0.41
ACSS2 Q9NR19 1/20 0.41
PKM P14618 1/20 0.41
FFAR1 O14842 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6002187 0.89 ALDH1A1 (0.46) SLC6A4ALDH1A1HSD17B10APPNPC1
SCHEMBL22663 0.86 CYP3A4 (0.59) ALDH1A1HSD17B10NPC1RAB9AL3MBTL1
SCHEMBL1746756 0.81 FFAR1 (0.58) FFAR1
SCHEMBL8517411 0.77 IKBKB (0.55) ALDH1A1HSD17B10TDP1NPC1RAB9A
SCHEMBL14185281 0.76 NPC1 (0.44) SLC6A4ALDH1A1HSD17B10TDP1NPC1
SCHEMBL27594903 0.76 ALDH1A1 (0.39) SLC6A4ALDH1A1HSD17B10TDP1NPC1
SCHEMBL1744698 0.75 RAB9A (0.46) ALDH1A1TDP1NPC1RAB9AL3MBTL1
SCHEMBL5539650 0.75 NPC1 (0.45) SLC6A4ALDH1A1HSD17B10APPTDP1
SCHEMBL29751999 0.74 STAT3 (0.44) SLC6A4ALDH1A1HSD17B10TDP1L3MBTL1
SCHEMBL2113508 0.74 NPC1 (0.47) SLC6A4ALDH1A1HSD17B10APPTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100497345-C 2, 3-dihydro-6-nitroimidazolo [2,1-b] oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2009-06-10 CN disclosed
CN-1878777-A 2,3-dihydro-6-nitroimidazo (2,1-b) oxazole compounds for the treatment of tuberculosis OTSUKA PHARMA CO LTD (JP) 2006-12-13 CN disclosed
EP-1678185-A1 2,3-DIHYDRO-6-NITROIMIDAZO [2,1-B] OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-07-12 EP disclosed
WO-2005042542-A1 2,3-DIHYDRO-6-NITROIMIDAZO (2,1-B) OXAZOLE COMPOUNDS FOR THE TREATMENT OF TUBERCULOSIS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2005-05-12 WO disclosed